Pfizer
- Nyota Wright
Nyota Wright is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as the Eliquis US Brand Strategy Lead at Pfizer. Previous roles at Pfizer include US Hospital Channel Director and Global Commercial Director for Eliquis, as well as several positions in Global Market Research focusing on swine and companion animal markets. Additionally, Nyota has contributed as a Monitoring and Evaluation Advisor during a fellowship with the Access Project. Earlier career experiences include serving as a Program Coordinator at Hofstra University and working as an Acquisition Policy Analyst at JPMorgan Chase. Nyota holds an MBA in Marketing from NYU Stern School of Business and a Graduate Certificate in Pharmaceutical Management from Stevens Institute of Technology.
Org chart
Upgrade to view 0 reports
Teams
This person is not in any teams
Offices
Pfizer
532 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.
